Literature DB >> 10777086

Anti-tuberculosis drug resistance in the West Province of Cameroon.

C Kuaban1, R Bercion, J Noeske, P Cunin, P Nkamsse, S Ngo Niobe.   

Abstract

SETTING: All 15 district hospitals of the West Province of Cameroon, between July 1997 and June 1998.
OBJECTIVE: To determine the prevalences of initial and acquired resistance to the main anti-tuberculosis drugs 2 years after the implantation of a tuberculosis control programme in the province.
METHODS: A total of 615 adults consecutively admitted to the 15 district hospitals with sputum smear-positive pulmonary tuberculosis were systematically studied. Sputum specimens collected from each patient were cultured on Lowenstein-Jensen medium. Testing of susceptibility to the major anti-tuberculosis drugs was performed by the indirect proportion method.
RESULTS: Growth of Mycobacterium tuberculosis complex strains was obtained from specimens of 566 (92%) of the 615 patients. The overall resistance rate (one or more drugs) was 26.9%, with initial resistance being 19.7% (86/437) and acquired resistance 51.1% (66/129). Initial resistance to isoniazid was the most common (12.1%), followed by streptomycin (11.7%), ethambutol (2.5%) and rifampicin (2.1%). Initial resistance was noted as 13.5% to one drug, 4.3% to two, 1.1% to three and 0.7% to four. Acquired resistance to isoniazid was the most frequent (41.1%), followed by streptomycin (26.4%), rifampicin (14.7%) and ethambutol (9.3%). Acquired resistance was 25.6% to one drug, 14.7% to two, 7% to three and 3.9% to four.
CONCLUSION: The proportion of resistant tuberculosis in the West Province is quite high. This underscores the need for the improvement of the control programme by introducing the DOTS strategy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10777086

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  14 in total

1.  Molecular characterization and drug resistance testing of Mycobacterium tuberculosis isolates from Chad.

Authors:  Colette Diguimbaye; Markus Hilty; Richard Ngandolo; Hassane H Mahamat; Gaby E Pfyffer; Franca Baggi; Marcel Tanner; Esther Schelling; Jakob Zinsstag
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

2.  First insight into Mycobacterium tuberculosis epidemiology and genetic diversity in Trinidad and Tobago.

Authors:  Shirematee Baboolal; Julie Millet; Patrick Eberechi Akpaka; Dottin Ramoutar; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

3.  Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon.

Authors:  Sara Ngo Niobe-Eyangoh; Christopher Kuaban; Philippe Sorlin; Patrick Cunin; Jocelyn Thonnon; Christophe Sola; Nalin Rastogi; Veronique Vincent; M Cristina Gutierrez
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

4.  Mycobacterium tuberculosis complex drug resistance pattern and identification of species causing tuberculosis in the West and Centre regions of Cameroon.

Authors:  Jean-Paul Assam-Assam; Veronique B Penlap; Fidelis Cho-Ngwa; Jean-Claude Tedom; Irene Ane-Anyangwe; Vincent P Titanji
Journal:  BMC Infect Dis       Date:  2011-04-15       Impact factor: 3.090

5.  Beijing/W genotype Mycobacterium tuberculosis and drug resistance.

Authors: 
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

6.  Underreported threat of multidrug-resistant tuberculosis in Africa.

Authors:  Yanis Ben Amor; Bennett Nemser; Angad Singh; Alyssa Sankin; Neil Schluger
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

7.  M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.

Authors:  Gibson S Kibiki; Bert Mulder; Wil M V Dolmans; Jessica L de Beer; Martin Boeree; Noel Sam; Dick van Soolingen; Christophe Sola; Adri G M van der Zanden
Journal:  BMC Microbiol       Date:  2007-05-31       Impact factor: 3.605

8.  Drug resistance profiles of Mycobacterium tuberculosis complex and factors associated with drug resistance in the Northwest and Southwest Regions of Cameroon.

Authors:  Henry D Meriki; Kukwah A Tufon; Pascal N Atanga; Irene N Ane-Anyangwe; Damian N Anong; Fidelis Cho-Ngwa; Theresa Nkuo-Akenji
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

9.  Prevalence and Drug Resistance Patterns of Mycobacterium tuberculosis among New Smear Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia.

Authors:  Berhanu Seyoum; Meaza Demissie; Alemayehu Worku; Shiferaw Bekele; Abraham Aseffa
Journal:  Tuberc Res Treat       Date:  2014-04-16

10.  Drug resistance of Mycobacterium tuberculosis isolates from tuberculosis lymphadenitis patients in Ethiopia.

Authors:  Fantahun Biadglegne; Belay Tessema; Ulrich Sack; Arne C Rodloff
Journal:  Indian J Med Res       Date:  2014-07       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.